Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.42 USD | -3.64% | +3.92% | +14.15% |
02/07 | Avid Bioservices Fiscal Q4 Loss Widens, Revenue Increases; Fiscal 2025 Revenue Outlook Set | MT |
02/07 | Transcript : Avid Bioservices, Inc., Q4 2024 Earnings Call, Jul 02, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.15% | 49Cr | |
+4.57% | 9.67TCr | |
+5.66% | 4.14TCr | |
-12.80% | 3.27TCr | |
+80.99% | 2.91TCr | |
-15.53% | 1.54TCr | |
-8.70% | 1.3TCr | |
-12.22% | 1.14TCr | |
+183.25% | 989.81Cr | |
+3.60% | 892.76Cr |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Transcript : Avid Bioservices, Inc., Q4 2024 Earnings Call, Jul 02, 2024